News & Articles
Selected Filters:
Avacta Group partners with Mologic to market SARS-CoV-2 lateral flow rapid antigen test
Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing
DiaSorin launches LIAISON SARS-CoV-2 TrimericS IgG test for determination of IgG antibodies
The test could be used to assess antibody response against the native spike protein of SARS-CoV-2 following COVID-19 vaccination
Expand your skills with these 4 free upcoming webinars
Explore topics from oligonucleotides and high-sensitivity troponin assays to therapeutic antibodies and advances in COVID-19 sample prep
FairJourney Biologics Group introduces Flow Eighteen38 for protein production and antibody characterization services
Flow Eighteen38 will provide purified proteins and data to accelerate the success of antibody projects
Aalto Bio launches breakthrough diagnostic material for Rubella
New capsid free antigen overcomes cross-reactivity difficulties, reducing the likelihood of false positives
BioMed X Institute starts new research project in drug delivery in collaboration with Janssen
New crowdsourcing project to examine the ‘Translocation of Complex Macromolecules Across the Intestinal Epithelial Barrier’
Access your 2021 Scientific Resource Bundles
Kickstart your new year with this compilation of top eBooks, techniques, webinars and videos across a range of scientific topics
ProBioGen licenses GlymaxX technology to AbbVie
Antibiotic Research UK welcomes INEOS Oxford Institute to combat antimicrobial resistance as an important step forward
The new institute aims to meet the urgent need to do more research into the antimicrobial resistance
Mission Bio launches single-cell multi-omics system for faster development of precision cancer therapies
The integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs
Rapid functional evaluation of virus-neutralizing antibodies using multi-parametric live cell analysis: Your questions answered
Watch this on-demand webinar to learn about an alternative assay that aims to identify virus-neutralizing antibodies in as little as five hours
Pfizer-BioNTech COVID-19 vaccine elicits antibodies that neutralize coronavirus mutations
These findings are crucial as rapidly spreading variants of SARS-CoV-2 have been reported in various countries
OXGENE introduces SLIM platform for discovery of antibodies against membrane proteins
The novel self-labelling mammalian display method identifies antibodies against membrane proteins in their native configuration
Boosting vaccine discovery & development in a post-pandemic era with fast, high-performance immunoassays
Guest editorial: Technology to meet the needs of faster vaccine development
Charles River acquires Distributed Bio
How to revolutionize your immunoassay development with SpyTag antibodies
Watch this on demand webinar to learn about SpyTag-SpyCatcher technology and how TrailBlazer Antibodies can transform your assay development
AstraZeneca’s COVID-19 vaccine authorized for emergency supply in the UK
Working with the UK government, first vaccinations are to begin early in the new year
Seegene’s COVID-19/FluA,B/RSV test with extraction-free feature now available in Europe
The real-time RT-PCR assay can simultaneously detect and differentiate 8 target genes, the first and only test to do so in the world
Catch highlights from the Virtual Biopharmaceutical Summit 2020
Top talks and resources exploring the latest research and methods in the field are now available on demand